Tang JP - Search Results

1

Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.

Guo K, Tang JP, Jie L, Al-Aidaroos AQ, Hong CW, Tan CP, Park JE, Varghese L, Feng Z, Zhou J, Chng WJ, Zeng Q. Guo K, et al. Among authors: tang jp. Oncotarget. 2012 Feb;3(2):158-71. doi: 10.18632/oncotarget.442. Oncotarget. 2012. PMID: 22374986 Free PMC article.

2

Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice.

Guo K, Tang JP, Tan CP, Wang H, Zeng Q. Guo K, et al. Among authors: tang jp. Cancer Biol Ther. 2008 May;7(5):750-7. doi: 10.4161/cbt.7.5.5764. Epub 2008 May 20. Cancer Biol Ther. 2008. PMID: 18364570 Free article.

3

Targeting intracellular oncoproteins with antibody therapy or vaccination.

Guo K, Li J, Tang JP, Tan CP, Hong CW, Al-Aidaroos AQ, Varghese L, Huang C, Zeng Q. Guo K, et al. Among authors: tang jp. Sci Transl Med. 2011 Sep 7;3(99):99ra85. doi: 10.1126/scitranslmed.3002296. Sci Transl Med. 2011. PMID: 21900592

4

Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels.

Guo K, Li J, Tang JP, Koh V, Gan BQ, Zeng Q. Guo K, et al. Among authors: tang jp. Cancer Biol Ther. 2004 Oct;3(10):945-51. doi: 10.4161/cbt.3.10.1111. Epub 2004 Oct 27. Cancer Biol Ther. 2004. PMID: 15326366 Free article.

5

Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.

Li J, Guo K, Koh VW, Tang JP, Gan BQ, Shi H, Li HX, Zeng Q. Li J, et al. Among authors: tang jp. Clin Cancer Res. 2005 Mar 15;11(6):2195-204. doi: 10.1158/1078-0432.CCR-04-1984. Clin Cancer Res. 2005. PMID: 15788667

6

PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.

Guo K, Li J, Wang H, Osato M, Tang JP, Quah SY, Gan BQ, Zeng Q. Guo K, et al. Among authors: tang jp. Cancer Res. 2006 Oct 1;66(19):9625-35. doi: 10.1158/0008-5472.CAN-06-0726. Cancer Res. 2006. PMID: 17018620

7

VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers.

Tang JP, Tan CP, Li J, Siddique MM, Guo K, Chan SW, Park JE, Tay WN, Huang ZY, Li WC, Chen J, Zeng Q. Tang JP, et al. Mol Cancer. 2010 May 28;9:128. doi: 10.1186/1476-4598-9-128. Mol Cancer. 2010. PMID: 20509867 Free PMC article.

8

PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

Wang H, Quah SY, Dong JM, Manser E, Tang JP, Zeng Q. Wang H, et al. Among authors: tang jp. Cancer Res. 2007 Apr 1;67(7):2922-6. doi: 10.1158/0008-5472.CAN-06-3598. Cancer Res. 2007. PMID: 17409395

9

Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide.

Liu BH, Jobichen C, Chia CSB, Chan THM, Tang JP, Chung TXY, Li J, Poulsen A, Hung AW, Koh-Stenta X, Tan YS, Verma CS, Tan HK, Wu CS, Li F, Hill J, Joy J, Yang H, Chai L, Sivaraman J, Tenen DG. Liu BH, et al. Among authors: tang jp. Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7119-E7128. doi: 10.1073/pnas.1801253115. Epub 2018 Jul 5. Proc Natl Acad Sci U S A. 2018. PMID: 29976840 Free PMC article.

10

A rapid HLA-DRB1*04 subtyping method using PCR and DNA heteroduplex generators.

Savage DA, Tang JP, Wood NA, Evans J, Bidwell JL, Wee JL, Oei AA, Hui KM. Savage DA, et al. Among authors: tang jp. Tissue Antigens. 1996 Apr;47(4):284-92. doi: 10.1111/j.1399-0039.1996.tb02555.x. Tissue Antigens. 1996. PMID: 8773317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters